L'Oréal delved into skin pigmentation disorders and how hormones affect skin and scalp health. On July 5, L'Oréal unveiled the Group's latest studies and innovations in the field of skin health at the 25th World Congress of Dermatology (WCD) 2023 held in Singapore. It is reported that the World Congress of Dermatology (WCD, World Congress of Dermatology) is held once every four years. This meeting, jointly organized by the International Federation of Dermatology Societies and the Singapore Dermatology Society, among others, brings together the world's leading dermatologists to focus on advances in major breakthroughs in dermatological science, including clinical practice, research, technology and innovation. L'Oreal's Dermatology Beauty presented the results of two global skin health studies conducted by La Roche-Posay and Vichy. Vichy conducted a large-scale study on how hormones affect skin and scalp health, which surveyed 20,000 women in 20 countries who shared information about how irregular cycles, postpartum and perimenopause affect self-perceptions of skin and scalp disorders and impact health. Of these women, 72% reported that this hormonal change had a negative impact on their health, and 61% reported that skin problems occur or worsen during the physiological period. La Roche-Posay conducted a study on pigmentation disorders with 48,000 subjects from 34 countries worldwide. The results showed that 50% of the subjects reported having pigmented skin disorders such as vitiligo, post-inflammatory hyperpigmentation and melasma; nearly one third (28%) of the subjects reported that their quality of life was severely affected as a result, and 44% of those with pigmented skin disorders said they covered up the skin in the area of the disorder. “Together with the dermatologist community, we are advancing skin health for all people, in their infinite diversity,” said Myriam Cohen-Welgryn, Worldwide President, L’Oréal Dermatological Beauty Division. “By helping increase scientific knowledge, creating new, sustainable products and augmented services, and supporting people in need, we are helping extend access to skin health to ever-more people around the world.”

Nine days after submitting its listing filing, MISIFU said it withdrew its listing filing after considering factors such as the company's own development and current industry regulatory policies. According to the official website of the National Equities Exchange and Quotations, Chinese beauty single-brand store MISIFU announced on July 4 that it had withdrawn its application for the public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange, saying that it had withdrawn its application for the public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange, taking into account factors such as the company's own development and current industry regulatory policies. Previously, after completing the counseling process for listing, MISIFU filed the application for public offering and listing of shares to unspecified qualified investors with the Beijing Stock Exchange on June 26. However, nine days after submitting the listing filing, MIS Skin hurriedly ended its IPO journey to the BSE. According to public information, MISIFU was established in Suzhou in 2011, and its eponymous brand MISIFU is positioned as "precision skin care", claiming that it is dedicated to creating a product system for Chinese skin characteristics. At present, its products cover more than 300 SKUs including skin care, color cosmetics and facial masks, and more than 10 kinds of series of kits with efficacy. The company was officially listed on the New Third Board in 2016 and was transferred to the New Third Board innovation layer on May 23, 2022. According to the IPO plan previously announced by MISIFU, if successfully listed, the expected number of shares to be issued will be no more than 25 million initial shares with an issue reserve price of RMB 8.00 per share (inclusive). The total amount of proceeds is expected to be 180 million yuan ($24.8 million), of which 118 million yuan ($16.3 million) will be used for marketing channel expansion projects, 22.15 million yuan will be used for R&D and testing upgrade projects, and 39.93 million yuan ($5.5 million) will be used for brand upgrade projects. It is worth mentioning that according to the previous fundraising plan, 12% of the funds are expected to be used for R&D upgrades, while over 65% of the funds will be used for marketing channel expansion. CHAILEEDO found that from 2016 to 2022, its performance has maintained a steady upward trend, especially from 2016 to 2018, and its revenue has maintained a high growth trend. However, since 2019, MISIFU's revenue growth has slowed down significantly, especially in 2020 when most of its chain stores were delayed in resuming work due to the pandemic, resulting in its revenue recording a low single-digit growth of only 2.99%. 2021 saw a small rebound in MISIFU's revenue growth, but its 2022 annual report shows that its revenue maintained a low-range growth of 3.74% last year. In terms of net profit, except for 2021, MISIFU has maintained a high growth, especially in 2016 just after listing, when its net profit recorded a high growth of 213.91% and has maintained a net profit increase of over 30% since then, except for the two years from 2020 to 2021 when it was greatly affected by the epidemic. In addition, its gross profit margin has also been maintained at a more stable level, with 41.32%, 40.76%, 44.90%, 47.78%, 46.59%, 46.52% and 51.25% from 2016 to 2022, respectively. It is worth mentioning that, compared to the growing sales expenses, the R&D expenses of MISIFU do not account for a large proportion of the total revenue. According to the public financial report, only after 2021 did MISIFU start to focus on R&D and increase its investment by a large amount, with 13 new R&D staff and a total R&D investment of 2,868,800 yuan ($396,035). According to the official website of MISIFU, it has been developing its brand on the basis of single-brand chain stores since its establishment. The number of its stores will exceed 500 in 2020, with an average annual sales output of 1-8 million per store per year, and plans to break through 2,000 stores by 2025. In terms of online channels, from the perspective of platform sales, the main online platforms of MISIFU are concentrated in Taobao and Douyin (the Chinese version of TikTok). Among them, MISIFU's Tmall flagship store has accumulated 677,000 followers. The overall monthly sales are not high. The best-selling product is sunscreen is 100+ pieces. In terms of Douyin channel, the highest-selling moisturizing cleanser has accumulated sales of 15,000 units, but the cumulative sales of other products have not exceeded 7,000 units.

Since June 21, the news about the special inspection of the illegal practice of "One Certificate, Multiple Usages" was released, and the related governance work is also being rolled out in full swing across the industry. Recently, the Chinese e-commerce platform Taobao issued an announcement to open a special governance operation for cosmetics of the illegal practice of "One Certificate, Multiple Usages", which was implemented on July 3, 2023. The illegal practice of "One Certificate, Multiple Usages" of cosmetics refers to the illegal labeling of products with words, trademarks or logos other than the cosmetic registration information or other means of applying special cosmetic registration certificate numbers or ordinary cosmetic filing numbers. According to Chinese cosmetic regulations, registered special-purpose cosmetics must strictly comply with one product, one certificate, one number. According to the announcement issued by Taobao merchant backend system Qianniu platform, according to the "Cosmetics Network Operation Supervision and Management Measures" and the special action of the illegal practice of "One Certificate, Multiple Usages", the platform has the following requirements for cosmetic qualification control in response to the relevant national requirements: If the goods released are cosmetics, merchants must correctly fill in the attribute "cosmetic record number/registration certificate number" and check the consistency of the completed special use cosmetic certificate number/non-special cosmetic record certificate number, product name and other information with the actual product and the corresponding product information published on the official website of the National Medical Products Administration. Moreover, according to the requirements on the display of cosmetic label information of "Cosmetics Network Operation Supervision and Management Measures", merchants are required to display the complete Chinese label information of cosmetics in the fourth main picture of the product, which clearly shows the product name, approval number/product implementation standard number, manufacturer and other information, where the product name and product implementation standard number should be prominently displayed in text form on their product display page. "The goods that do not fill in or display the cosmetic registration number/registration certificate number or fraudulently use or apply the cosmetic registration certificate number/record number as required will not be sold in their online stores, deleted, and deducted from the score." The announcement suggests that if a merchant currently sells a cosmetic product with a certificate number that is inconsistent with the product, the merchant needs to first take down the product and modify it correctly before re-releasing it. For the cosmetic sets, the announcement also pointed out that the attribute "cosmetic record number/registration certificate number" should be filled in with the main commodity, and the rest of the commodity certificate number information can be displayed on the commodity page. For the sets of special-purpose cosmetics and original cosmetics, the attribute should be filled in with the special cosmetics certificate number information. It is worth mentioning that on July 3, Alibaba's comprehensive B2B e-commerce platform 1688 launched "Management Norms of Cosmetics Industry on 1688 Platform", also clearly indicates that the failure to fill in the required "special-purpose cosmetics certificate number", as well as fill in the information with the physical, official website information inconsistencies, etc., will be not be sold on the online stores, deduct points. The company also emphasized that if the product is a custom cosmetic processing category, the shopkeeper's "cosmetic production license" must be submitted before releasing the product. In fact, since June 21, the news about the special inspection of the illegal practice of "One Certificate, Multiple Usages" was released, and related governance work is also being carried out in full swing across the industry. Such as Tibet, Guangdong, Zhejiang, Jiangxi and many other places have now started the enterprise of self-examination and rectification. Among them, the Guangzhou Municipal Administration of Market Supervision has announced the first penalty case. The packaging containers of “Hanlu Amino Acid Shampoo” produced by Guangzhou Pinying Biotechnology Company were marked with the words "Nanjing Tong Ren Tang Green Gold Home", belonging to the cosmetics labeling prohibited labeling content. Guangzhou Pinying Biotechnology Company was fined a total of 16.2 million yuan ($2.2 million).

In the past years, Adidas personal care has been deeply involved in the male market, this is the first time Adidas launched women's products. Recently, Adidas personal care brand under Coty officially launched its Vitality Purifying series of body wash, the whole series contains 7 products, divided into men's and women's series. It is worth noting that this is the first time that Adidas personal care brand launched women's products. Qiao Xuedong, general manager of mass beauty in Coty China, said that in the category of shower gel in the Chinese market, male shower gel products account for about 2%, and the rest comes from the female and unisex market. In the past years, Adidas personal care has been deep in the male market, "This time we want more people to know our products and expand from a brand for men to a brand for all consumers." In addition, Qiao Xuedong also said that the previous more popular products is a series of triple, set cleanser, shampoo, bath in a bottle. But the personal care needs of men's groups are changing, boys are becoming more and more sophisticated. The product line is not detailed enough. The launch of the shower gel series is in the cognitive specificity of a niche sector, so as to make the market bigger. It is worth mentioning that as a perennial leader in the men's shower gel sector, Adidas personal care will focus on gender-free products in the future, to expand into the field of skin care and perfume.

The approval of Leaping Bunny underscores Avon's 30-year commitment to animal welfare. Avon, the global beauty company, has recently received approval under the Cruelty-Free International Leaping Bunny Program. This marks a significant milestone for the company, which has been working towards becoming a more ethical and sustainable business. It is reported that the Leaping Bunny program is an internationally recognized certification program that aims to promote cruelty-free practices in the cosmetics industry. Companies that receive approval under the program must meet strict criteria, including a ban on animal testing at any stage of product development and a commitment to using only cruelty-free ingredients. Avon's approval under the Leaping Bunny program is a testament to the company's commitment to ethical and sustainable practices. The first of Avon’s ranges to receive Leaping Bunny approval are fragrance, Avon Care and Anew. The company has been working towards becoming more sustainable in recent years, with a focus on reducing its environmental footprint and improving the welfare of animals used in its products. Avon's commitment to animal welfare can be seen in its decision to ban animal testing for its products in 1989. Since then, the company has been working towards finding alternative methods for product testing, such as in vitro testing and computer simulations. Avon has also been working to remove animal-derived ingredients from its products. The company has stated that it aims to use only synthetic or plant-based ingredients in its products by 2025, which will further reduce its impact on animal welfare. By receiving approval under the Leaping Bunny program, Avon has demonstrated its commitment to ethical and sustainable practices. The company has shown that it is possible to create high-quality cosmetic products without compromising on animal welfare or the environment. Global consumer demand for cruelty-free products is impacting how brands operate, as demonstrated by the 190% increase in brands enquiring about approval with Leaping Bunny since 2017. Said Michelle Thew, Cruelty Free International CEO, “I am delighted to announce our partnership with Avon. To work with them to help end animal testing for cosmetics and declare their fragrance, Avon Care and Anew ranges officially approved under the Leaping Bunny Programme is a real milestone for the global brand. I look forward to our continued partnership to approve the entire Avon product range over the next 12 months. Welcome to the Leaping Bunny family!”

In the new store, nearly 130 brands of new products, celebrity fragrances and classic designer fragrances are sold. It is reported that British fragrance retailer The Perfume Shop will open its latest "new and improved experiential store" at Swords Pavilions shopping center in Dublin on Friday (July 7). The Perfume Shop introduces the experiential store, which will include digital support, a personalized ribbon dispenser, free gift wrapping and recycling services. Customers who bring in their used perfume bottles for recycling will receive a 15 percent discount on their next perfume purchase. The official website shows that The Perfume Shop has 215 offline stores in the UK, selling nearly 130 branded fragrances, including well-known perfume brands such as Hugo Boss, Paco Rabanne, Gucci, Hermès and Maison Margiela. The Perfume Shop is committed to reducing energy consumption by 30% by 2030 compared to 2015 and introducing features such as energy-efficient LED lighting. Where possible, existing materials and equipment will be retained or reused. In the new store, new products from nearly 130 brands, celebrity fragrances and classic designer fragrances are for sale. The Perfume Shop will also be giving away a free bottle of perfume to the first 30 customers with a purchase of more than 70 euros during the two days of opening. In this year's Father's Day sale, The Perfume Shop reported an outstanding performance during the period, selling a record 224000 bottles of fragrances in the 14 days leading up to the big day, June 18, 2023. Compared to the same period in 2022, brick-and-mortar and online retail sales in the month leading up to Father's Day were up 9.1 %.

Toy Box is reportedly planning to launch its first two brands, Drunk Diamond, a jewelry cleaner, and Polite Society, a cosmetic brand. Too Faced Cosmetics founders Jarrod Blandino and Jeremy Johnson have announced their return to the beauty industry with the launch of beauty incubator Toy Box Brands, which the pair reportedly sold their brand Too Faced to Estée Lauder for $1.45 billion back in 2016. Johnson and Blandino reportedly resigned from Too Faced on June 30, 2022, saying at the time that they wanted to pursue new opportunities. Blandino has since said he discussed trademark issues regarding Toy Box on July 1. This month, the startup launched a jewelry cleaner called "Drunk Diamond." In August, Toy Box Brands will also launch a line of Polite Society cosmetics, which, according to the founder, is aimed at GenZ and millennials. And the line will debut during Madonna's world tour. Meanwhile, Polite Society will also debut at Ulta Beauty's 850 stores in August. The Polite Society cosmetics line, which promotes clean beauty and is committed to ingredient transparency, will reportedly be categorized under Ulta Beauty's Clean Beauty segment. The Toy Box team is made up of former Too Faced employees and currently consists of 17 members, with the number climbing to 30 once Toy Box really gets going, according to the two Toy Box founders, who say they plan to launch up to 16 brands over the next decade. Toy Box is reportedly entering a popular category. The diversified beauty companies such as Sephora, Maesa and L'Oreal are already involved in the incubator business.

Kenvue, a consumer health business under Johnson & Johnson, is expected to be listed on the New York Stock Exchange under the ticker “KVUE”. Kenvue priced its IPO at $22 per share, which made Kenvue valued at around $41 billion. Johnson & Johnson's consumer health subsidiary, Kenvue, is expected to trade Thursday morning on the New York Stock Exchange under the ticker “KVUE.” Kenvue, a consumer health business under Johnson & Johnson, plans to issue 151.2 million common shares in its IPO, with an offering price range of $20 to $23 per share. Goldman Sachs & Co. LLC, J.P. Morgan, and BofA Securities are acting as joint lead book-running managers for the IPO. Citigroup, Deutsche Bank Securities, BNP Paribas, HSBC, RBC Capital Markets, and UBS Investment Bank are acting as book-running managers for the IPO Kenvue's offering size has been further increased to 172.8 million common shares, with an offering price of $22 per share. Based on this offering price, Kenvue is expected to raise over $3.8 billion through this IPO. If the overallotment option is exercised, the total fundraising size will exceed $4 billion, and the IPO market capitalization will exceed $41 billion. This means that Kenvue will not only become the largest U.S. IPO of 2023 so far but also the largest U.S. IPO since November 2021. The amount raised by Kenvue will be twice the sum of the fundraising size of all the companies that have completed IPOs on the U.S. stock market in 2023. Currently, Kenvue has a total of 44 brands under its umbrella, with more than 10 brands generating over $400 million in net sales in 2022. Many of its brands hold the number one position in North American or global sub-markets, including well-known brands such as Tylenol, Neutrogena, Listerine, Johnson's Baby Powder, and Band-Aid. The overall business of Kenvue is divided into three segments. The Skin Health and Beauty segment includes face and body care, hair care, and sun care products, with major brands such as Neutrogena, Aveeno, and OGX. The Essential Health segment includes oral care, baby care, and other essential health products for women's health and wound care, with major brands such as Listerine, Johnson's, Band-Aid, and Stayfree. The Self Care segment includes cough, cold, and allergy products, pain relief, and other self-care products such as digestive health and smoking cessation, with major brands such as Tylenol, Nicorette, and Zyrtec. In the year 2022, Kenvue delivered net sales of $14.95 billion, slightly lower than the $15.05 billion in 2021, with over half of the revenue coming from outside North America. Kenvue’s net profit reached $2.09 billion, which saw a growth of 2.8% compared to 2022. In Q1 2023, Kenvue reported net sales of $3.85 billion, with an increase of 7.3% compared to 2022 Q1. Johnson & Johnson said after the completion of the IPO, Johnson & Johnson will own 1,716,160,000 shares of Kenvue’s common stock, representing 91.9% of the total outstanding shares of Kenvue’s common stock.

Johnson & Johnson has announced that its subsidiary, Kenvue Inc., which includes its Consumer Health Business, has started a roadshow for its IPO with a price range of $20 to $23 per share and to raise about $3.5 billion. Johnson & Johnson has announced that its subsidiary, Kenvue Inc., which includes its Consumer Health Business, has started a roadshow for its IPO. Johnson & Johnson has initiated a roadshow for its upcoming initial public offering, which will involve selling 151,204,000 shares of common stock. And Kenvue is planning to give the underwriters a 30-day option to buy up to 22,680,600 additional shares of its common stock to cover any over-allotments. Johnson & Johnson said Kenvue has filed an application to list its common stock on the New York Stock Exchange under the ticker symbol "KVUE" and is anticipating an IPO price range of $20 to $23 per share. The spinoff, with an estimated valuation of approximately $40 billion at the given share price range, has the potential to become the biggest initial public offering in the US market for such offerings so far this year, given the subdued market conditions. In November 2021, Johnson & Johnson revealed its plan to spin off its Consumer Health division into a new public company. Johnson & Johnson pointed out that Kenvue is inspired by two powerful ideas: “ken” – meaning knowledge, an English word primarily used in Scotland, and “vue,” referencing sight. With rich knowledge of human needs and deep consumer insights, Kenvue will deliver meaningful, personal health solutions. In terms of business, Kenvue has a total of 44 brands, including four major brands with revenue exceeding $1 billion and 20 brands with revenue over $150 million. The overall business is divided into three segments. Skin Health and Beauty segment, product categories include face and body care and hair, sun, and other. Major brands in the segment include Neutrogena, Aveeno, and OGX. Essential Health segment, product categories include oral care, baby care, and other essential health (women’s health and wound care). Major brands in the segment include Listerine, Johnson’s, Band-Aid, and Stayfree. In the Self Care segment, product categories include cough, cold, and allergy, pain Care; and other self-care (digestive health, smoking cessation, and other). Major brands in the segment include Tylenol, Nicorette, and Zyrtec. Johnson & Johnson said after the completion of the IPO, Johnson & Johnson will own 1,716,160,000 shares of Kenvue’s common stock, representing 91.9% of the total outstanding shares of Kenvue’s common stock (or 90.8% if the underwriter's exercise in full their over-allotment option).

Retail sales of cosmetics in Hong Kong reached HK$2.64 billion ($337.2 million) in May 2023 compared to the same period last year, a significant increase of 51.5%. On July 3, the Hong Kong Census and Statistics Department released data showing that the provisional estimate of the value of total retail sales in May 2023 was HK$34.5 billion ($4.4 billion), up 18.4% year-on-year. The revised estimate of the value of total sales in April 2023 was up 14.9% compared with the same period in 2022. Compared with 2022, the provisional estimate of the value of total retail sales in the first five months of 2023 combined was up 21.0%. Of the overall sales, online sales were HK$2.2 billion ($281 million), which account for 6.3% of the total retail sales, down 3.7% from the same period in 2022. The revised estimate of the value of retail online sales for April 2023 was down 13.2% from the same period in 2022. The provisional estimate for the value of retail online sales for the first five months of 2023 combined declined 6.6% compared to the same period in 2022. Excluding price changes during the period, the provisional estimate for the number of total retail sales in May 2023 rose 16.5% from the same month in 2022. The revised estimate for the number of total retail sales in April 2023 rose 13.1% from the same month in 2022. The provisional estimate of total retail sales volume for the first five months of 2023 combined is up 19.2% compared to the same period in 2022. By product category, the value of sales of jewelry, watches and clocks and valuable gifts rose by 51.8% in May 2023 compared with the same month in 2022. The value of sales of pharmaceuticals and cosmetics rose by 51.5% to HK$2.64 billion ($337.2 million). (Credit: from the Hong Kong Census and Statistics Department) A spokesman for the Hong Kong government said that with the continuous improvement in the consumer atmosphere and the number of visitors to Hong Kong, the total value of retail sales rose significantly year-on-year in May. For the future, the spokesman pointed out that the recovery of tourism and local consumption demand should continue to help the retail industry performance, the government will also issue consumption vouchers to provide further support.

It is reported that Lalami has incubated Naris, Byphasse, Ziaja, Gifrer and other overseas beauty brands. Yesterday (July 3), the IPO status of Guangzhou Lalami Information Technology Co., Ltd. (abbreviated as "Lalami") on the main board of the Shenzhen Stock Exchange was changed to "withdrawn" because the company applied for withdrawal of its application for listing. (Credit: from Shenzhen Stock Exchange ) According to the prospectus, Lalami is an integrated e-commerce service provider for overseas quality cosmetic brands. The company's main business includes Internet retail services and offline distribution, and the services provided to brands cover brand positioning, brand planning, etc. According to the company's official website, Lalami was established in 2012 and entered the e-commerce sector in 2014, shifting its business to provide one-stop brand management services in 2016. Li Tiantian, the founder of Lalami, previously said in a public interview with the media that the performance of Lalami's beauty segment had doubled continuously since the beginning of its entry into the e-commerce sector in 2014. It is reported that, as of the date of this prospectus, the company has incubated Naris, Byphasse, Ziaja, Gifrer, Casmara and other overseas beauty brands, and cooperated with brands in Japan, Spain, France, Poland, Australia, Belgium, the United States and many other countries or regions. For each period of the reporting period, the top five brands accounted for 86.44%, 90.80%, 89.84% and 89.47% of the Company's total main business revenue respectively, representing a high degree of concentration in brand sales. In terms of revenue, according to the prospectus published by Lalami, the Company achieved operating revenues of approximately 761 million yuan ($105.2 million), 784 million yuan ($108.3 million), 840 million yuan ($116 million) and 424 million yuan ($58.6 million) for 2019, 2020, 2021 and January-June 2022 respectively. During the same period, net profits were 63,874,800 yuan ($8.8 million), 58,088,200 yuan ($8 million), 60,175,000 yuan ($8,3 million) and 14,690,000 yuan ($2 million) respectively. It is reported that in June 2022, Lalami submitted the "Approval for the Company's Initial Public Offering of Shares (A-share SSE Main Board and Shenzhen Stock Exchange Main Board, B-share)", officially taking the first step towards the IPO. In July, Lalami officially announced its prospectus to be listed on the Shenzhen Stock Exchange Main Board. Lalami originally intended to issue no more than 20 million shares on the main board of the Shenzhen Stock Exchange, accounting for no less than 25% of the total share capital after the issue, and originally intended to raise 578,143,200 yuan ($79.9 million) for the brand incubation and operation promotion construction project, comprehensive operation centre construction project, information system construction project and supplementary working capital project.

On July 3, the 25th World Congress of Dermatology kick off in Singapore, with Galderma, as well as international beauty giants L’Oréal, Procter & Gamble, and Unilever, participating in the event. Can dermatology become the next trend in the beauty industry? Cited: srisriholistichospitals Recently, Swiss dermatology and skincare giant Galderma raised $7.2 billion through private equity, after considering an IPO earlier this year, which was postponed due to the bankruptcy crisis of its IPO global coordinator. On July 3, the 25th World Congress of Dermatology kicks off in Singapore, with the participation of Galderma and international beauty giants such as L’Oréal, and Procter & Gamble. could dermatology be the next trend in the beauty industry? What is Dermatology? Today (July 3), the 25th World Congress of Dermatology (WCD) officially kicked off in Singapore. The WCD is one of the largest international conferences in the field of dermatology, organized by the International League of Dermatological Societies (ILDS). The first WCD was held in Paris in 1889. Now, it is held every four years, with the most recent being the 24th WCD held in Milan, Italy in June 2019. This congress has attracted beauty industry and dermatology professionals from around the world, including international beauty giants L’Oréal, Procter & Gamble, and Unilever, as well as Swiss dermatology skincare giant Galderma. In addition, Chinese beauty brands Winona, and Yatsen participated in this congress. Dermatology is a medical specialty that focuses on the diagnosis, treatment, and prevention of conditions related to the skin, hair, nails, and mucous membranes. Cited: Puig's APIVITA brand The skin is the largest organ of the body, and dermatology plays a crucial role in maintaining its health and addressing various skin concerns. They are trained to identify and treat common skin conditions such as acne, eczema, psoriasis, dermatitis, fungal infections, warts, and skin allergies. They also diagnose and treat skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma. Dermatology encompasses both medical and cosmetic aspects. This aspect of dermatology focuses on improving the appearance of the skin. Dermatologists may offer various cosmetic procedures such as Botox injections, dermal fillers, chemical peels, laser treatments, microdermabrasion, and more. These treatments aim to reduce signs of aging, improve skin texture and tone, and address specific aesthetic concerns. Overall, dermatology is a specialized medical field that focuses on promoting skin health, diagnosing and treating skin conditions, and enhancing the appearance of the skin. How do global beauty giants enter the dermatology business? As dermatology receives increasing attention, international beauty giants are gradually expanding their businesses in this area. In February this year, Myriam Cohen-Welgryn, Global President of L'Oréal Active Cosmetics, announced on her LinkedIn account that L'Oréal Active Cosmetics had been officially renamed L'Oréal Dermatological Beauty. This division includes brands such as La Roche-Posay, Vichy, CeraVe, Decléor, SkinCeuticals, and the medical skincare brand Skinbetter Science, which was acquired in 2022. L'Oréal stated that the Dermatological Beauty division can rely on innovation based on scientific progress, such as microbiome and exposome, as well as services related to strong expertise in the field of beauty technology. The company has established trust relationships with over 250,000 doctors worldwide, including dermatologists, pediatricians, esthetic doctors, and general practitioners. This large network of partners and proximity allows L'Oréal to design and test its products, especially with dermatologists and other skin experts, to better meet their expectations and those of patients. Cited: L'Oréal's Vichy Brand In 2022, L'Oréal Active Cosmetics (now Dermatological Beauty) achieved sales of 5.125 billion euros ($5.58 billion), a year-on-year growth of 30.6%, once again becoming the fastest-growing division. In addition to L'Oréal, Shiseido also sees dermatology as a new growth opportunity for the group. On May 22, Shiseido announced that from January 1, 2024, Shiseido Japan will take over the business of Shiseido Pharmaceutical through a company split (absorption-type split). Shiseido stated that on February 10, the group launched its mid-term strategy, "SHIFT 2025 and Beyond," with "Clean & Dermatology" and "Inner Beauty" as the new growth opportunity. Shiseido also emphasized that clean and dermatology refer to the market segment combining cleansing cosmetics free of ingredients considered to be skin irritants with dermatological cosmetics based on dermatology. As early as 2022, Shiseido had begun to enter the dermatology business. In August 2022, Shiseido's cooperate fund led the investment in the Chinese recombinant collagen company Trautec. In September, Shiseido acquired Gallinée, a British microbial skincare brand founded in 2014 by pharmacist Marie Drago, who is highly recognized in the field of skin microbiota. Skin microbiota plays a crucial role in protecting us from external threats. Gallinée provides a selection of scientifically supported beauty products that contain a patented blend of prebiotics, probiotics, and postbiotics to enhance and nourish the skin's microbiome. In 2022, Shiseido's net profit was down 27.1% compared to 2021. The decline in performance may be due in part to Shiseido's focus on dermatology as the new growth opportunity in its mid-term strategy. On June 26, Swiss dermatology leader Galderma announced that it raised $1 billion through private equity to improve its balance sheet and accelerate its organic growth driven by its unique comprehensive dermatology strategy. Galderma also said that it still considered an IPO for the company, which would be an important step for it to become a global leader in dermatology. Cited: Galderma's Cetaphil brand Established in 1981, Galderma is a global emerging leader in the pure dermatology category in Switzerland, with three subcategories: injectable aesthetics, dermatological skincare, and therapeutic dermatology. Galderma reported that its net sales in 2022 reached $3.76 billion, a YoY increase of 13.9% calculated at a fixed exchange rate. In addition, the company's profitability in 2022 exceeded expectations, with its core EBITDA increasing by 14.5% YoY at a fixed exchange rate, reaching $791 million. As early as 2021, EQT AB, the owner of Galderma, expressed its desire to list Galderma for an IPO, which was delayed due to the bankruptcy crisis of its IPO global coordinator. Sources familiar with the matter have revealed that EQT may aim to raise as much as €3 billion ($3.2 billion) through Galderma's IPO. It is reported that if Galderma goes public successfully, Galderma could have a valuation of up to CHF 20 billion ($22.26 billion). Galderma is also expected to become a global leader in dermatology and one of the most promising companies in the beauty industry. In addition, Spanish beauty giant Puig has appointed Marc Toulemonde, who has worked at L'Oréal for over 20 years, as the new President of its Derma division. Beiersdorf acquired Belgian life science company S-Biomedic NV in December 2022 to accelerate the development of its microbiome-based skincare products. Last December, Amorepacific signed a cooperation agreement with Johns Hopkins University on dermatology, covering basic and clinical research to study new targets and mechanisms, and to conduct clinical bioactivity tests on materials developed by Amorepacific. In April of this year, the parent company of Avène, Pierre Fabre Group, acquired the skin cosmetics brand Même. It is clear that an increasing number of beauty giants are entering the dermatology business, seeing it as another new growth opportunity. Can dermatology become the next trend in the beauty industry? Dermatology, the branch of medicine focused on the diagnosis and treatment of skin conditions, has always played a significant role in the beauty industry. Dermatology is based on scientific research and medical knowledge, which gives it credibility and trust among consumers. People are increasingly seeking evidence-based solutions for their skin concerns rather than relying solely on marketing claims. In addition, with the rise of social media and easy access to information, there has been a surge in skincare awareness among consumers. People are becoming more educated about their skin and are seeking professional advice from dermatologists to achieve optimal skin health. Dermatology offers a wide range of advanced treatments for various skin conditions. From laser therapies to injectables and advanced skincare products, dermatologists have access to the latest technologies and techniques that can provide effective results. Dermatologists are skilled in assessing individual skin types and conditions, allowing them to provide personalized treatment plans. This tailored approach resonates with consumers who want customized solutions for their specific skin concerns. Cited: L’Oréal's Skinbetter Science Brand Dermatology focuses not only on treating existing skin issues but also on preventive measures. Dermatologists educate individuals about proper skincare routines, sun protection, and lifestyle factors that can contribute to skin health. This preventive aspect is gaining attention as people realize the importance of maintaining healthy skin. Many skincare brands now collaborate with dermatologists to develop products or endorse their formulations. This integration of medical expertise and beauty industry marketing helps to bridge the gap between medical dermatology and consumer beauty products. In addition, more and more beauty brands are collaborating with dermatology experts and doctors to offer professional skin diagnosis services, providing consumers with personalized skin care solutions. This trend also meets consumers' needs for health and personalization, so in the future, dermatology may become an important trend in the beauty industry.